Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Martin

Showing results (151-160 of 226) with videos related to

Pageof 23
Sort By:
FEBS Letters|February 10, 1992
Efficient thyroid hormone formation by in vitro iodination of a segment of rat thyroglobulin fused to Staphylococcal protein AM Asunción, R Ingrassia, J Escribano, et al.
Zeitschrift Fur Kardiologie|January 1, 1990
Properties of a novel plasminogen activator (BM 06.022) produced in Escherichia coliU Martin, S Fischer, U Kohnert, et al.
Transplantation Proceedings|March 20, 1999
Porcine endogenous retrovirus is transmitted neither in vivo nor in vitro from porcine endothelial cells to baboonsU Martin, G Steinhoff, V Kiessig, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 1, 1995
Absorption and clearance of ceftazidime during CAPDW D Plant, U Martin, W Barron, et al.
Thrombosis and Haemostasis|May 6, 1991
Thrombolysis with an Escherichia coli-produced recombinant plasminogen activator (BM 06.022) in the rabbit model of jugular vein thrombosisU Martin, S Fischer, U Kohnert, et al.
Thrombosis Research|August 1, 1990
Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patientsJ Harenberg, B Kallenbach, U Martin, et al.
British Journal of Clinical Pharmacology|July 1, 1995
Factors affecting the absolute bioavailability of nifedipineT J Rashid, U Martin, H Clarke, et al.
Clinical Science (London, England : 1979)|July 24, 2003
Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetesV Toescu, S L Nuttall, U Martin, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1992
Pharmacokinetic and thrombolytic properties of unglycosylated recombinant tissue-type plasminogen activator (BM 06.021) produced in Escherichia coliU Martin, S Fischer, U Kohnert, et al.
Lancet (London, England)|September 30, 1998
Oxidative stress after thrombolysisM J Landray, S L Nuttall, C Lydakis, et al.
Pageof 23

Showing results (151-160 of 226) with videos related to

Sort By:
Pageof 23
FEBS Letters|February 10, 1992
Efficient thyroid hormone formation by in vitro iodination of a segment of rat thyroglobulin fused to Staphylococcal protein AM Asunción, R Ingrassia, J Escribano, et al.
Zeitschrift Fur Kardiologie|January 1, 1990
Properties of a novel plasminogen activator (BM 06.022) produced in Escherichia coliU Martin, S Fischer, U Kohnert, et al.
Transplantation Proceedings|March 20, 1999
Porcine endogenous retrovirus is transmitted neither in vivo nor in vitro from porcine endothelial cells to baboonsU Martin, G Steinhoff, V Kiessig, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 1, 1995
Absorption and clearance of ceftazidime during CAPDW D Plant, U Martin, W Barron, et al.
Thrombosis and Haemostasis|May 6, 1991
Thrombolysis with an Escherichia coli-produced recombinant plasminogen activator (BM 06.022) in the rabbit model of jugular vein thrombosisU Martin, S Fischer, U Kohnert, et al.
Thrombosis Research|August 1, 1990
Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patientsJ Harenberg, B Kallenbach, U Martin, et al.
British Journal of Clinical Pharmacology|July 1, 1995
Factors affecting the absolute bioavailability of nifedipineT J Rashid, U Martin, H Clarke, et al.
Clinical Science (London, England : 1979)|July 24, 2003
Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetesV Toescu, S L Nuttall, U Martin, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1992
Pharmacokinetic and thrombolytic properties of unglycosylated recombinant tissue-type plasminogen activator (BM 06.021) produced in Escherichia coliU Martin, S Fischer, U Kohnert, et al.
Lancet (London, England)|September 30, 1998
Oxidative stress after thrombolysisM J Landray, S L Nuttall, C Lydakis, et al.
Pageof 23